Bellerophon to Present at the H.C. Wainwright Global Life Sciences Conference
Bellerophon Therapeutics (Nasdaq: BLPH) announced that CEO Fabian Tenenbaum will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. The presentation will be available on-demand starting March 9, 2021, on the company’s website. Bellerophon focuses on developing innovative therapies for cardiopulmonary and infectious diseases, including its proprietary INOpulse® program, a pulsatile nitric oxide delivery system. For more information, visit bellerophon.com.
- None.
- None.
WARREN, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.
The presentation will be available on-demand beginning on Tuesday, March 9, 2021, in the Investors section on the Company’s website at www.bellerophon.com.
About Bellerophon
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary and infectious diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system. For more information, please visit www.bellerophon.com.
Contacts
| At W2O Group: | At LifeSci Advisors: |
| Julie Normart | Brian Ritchie |
| (559) 974-3245 | (212) 915-2578 |
| jnormart@w2ogroup.com | britchie@lifesciadvisors.com |
FAQ
When is Bellerophon Therapeutics presenting at the H.C. Wainwright Global Life Sciences Conference?
Where can I watch Bellerophon Therapeutics' presentation?
What is the focus of Bellerophon Therapeutics?
What is the INOpulse® program by Bellerophon?
